Report of Analysis
Client / Product Manufacturer
BioKraft Labs GmbH ↗
Authorized Clinical & Research Formulation Partner • Frankfurt am Main, Germany
Sample received: 08/12/26
Analysis conducted: 08/13/26
Certificate ID: BK-COA-868187
Batch / Lot: LOT-2026-151
Product: Aventra Plus™ (Tirzepatide 30 mg) ↗
Appearance: Sterile lyophilized cake in borosilicate vial
Qualitative and quantitative chemical analysis by RP-HPLC with UV detection
Results
Identity: Aventra Plus™ (Tirzepatide 30 mg)
Quantity: 30.72mg
Purity: 99.479%
DAD1 A, Sig=220,4 Ref=off
CHROMATE HPLC 300 250 200 150 100 0 mAU 5 10 15 20 min 18.410 min MAIN PEAK Area: 99.479%
Aventra Plus™ (Tirzepatide 30 mg)
Tested Batch Vial
Lucas Weber
Lucas Weber
Principal Analytical Chemist
DIGITAL RECORD BK-COA-868187 coacertificates.com ↗
Produced: 08/15/26
Retest Due: 08/15/28
Independent Analytical Laboratory Report • Accredited in accordance with ISO/IEC 17025:2017 & cGMP European Directives • Frankfurt am Main, Germany.
The results reported relate solely to the sample tested. Authenticity can be verified at coacertificates.com using the unique certificate ID.